Validation of Hyponatremia as a Prognostic Predictor in Multiregional Upper Tract Urothelial Carcinoma

Hyponatremia has been shown to be associated with prognosis in various cancers, but its role in upper tract urothelial carcinoma (UTUC) is largely unidentified. We created an international multiregional cohort of UTUC, consisting of 524 and 213 patients from Taiwan and the U.S., to validate the significance of hyponatremia. Clinicopathologic characteristics were compared according to the presence of hyponatremia. Univariate and multivariate Cox regression models were used to investigate the association of hyponatremia with disease progression and survival. The impact of hyponatremia in patients from distinct regions was also analyzed. Hyponatremia was found in 143 (19.4%) patients. Hyponatremic patients had significantly worse Eastern Cooperative Oncology Group (ECOG) performance status (p = 0.00001) and higher pT stage (p = 0.002). In multivariate analysis, hyponatremia was an independent prognostic factor for progression (HR 1.585, 95% CI 1.115–2.253, p = 0.010), cancer-specific death (HR 2.225, 95% CI 1.457–3.397, p = 0.0002), and overall mortality (HR 1.819, 95% CI 1.299–2.545, p = 0.0005). Kaplan–Meier analysis showed the consistent adverse effect of hyponatremia on all outcomes in patients from Taiwan and the U.S. (all p < 0.05). Hyponatremia is commonly accessible and can serve as a negative marker for both the general health condition and disease severity of UTUC patients. A similar implication of hyponatremia in progression and survival despite patients’ region of presentation suggests its general applicability across different ethnicities.

[1]  D. Santini,et al.  The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases , 2018, Supportive Care in Cancer.

[2]  Y. Lotan,et al.  Preoperative predictors of nonorgan-confined disease in upper-tract urothelial carcinoma differ between China and the United States. , 2018, Urologic oncology.

[3]  Y. Okuno,et al.  Adjuvant chemotherapy improves survival of patients with high-risk upper urinary tract urothelial carcinoma: a propensity score-matched analysis , 2017, BMC Urology.

[4]  Y. Lotan,et al.  A Multi‐Institutional Comparison of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United States , 2017, The Journal of urology.

[5]  R. Zietse,et al.  Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines. , 2017, Journal of the American Society of Nephrology : JASN.

[6]  J. Castillo,et al.  The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients , 2016, BMC Cancer.

[7]  E. Bae,et al.  Prognostic impact of hyponatraemia in patients with colorectal cancer , 2015, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[8]  S. Popat,et al.  Resolution of severe hyponatraemia is associated with improved survival in patients with cancer , 2015, BMC Cancer.

[9]  R. Berardi,et al.  Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma , 2015, Supportive Care in Cancer.

[10]  N. Nonomura,et al.  Preoperative risk stratification for cancer-specific survival of patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy , 2015, International Journal of Clinical Oncology.

[11]  T. Choueiri,et al.  The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database Consortium. , 2014, European urology.

[12]  M. Rosner,et al.  Electrolyte disorders associated with cancer. , 2014, Advances in chronic kidney disease.

[13]  A. Maji,et al.  The Incidence of Hyponatraemia and Its Effect on the ECOG Performance Status among Lung Cancer Patients. , 2013, Journal of clinical and diagnostic research : JCDR.

[14]  K. Fujita,et al.  Preoperative serum sodium is associated with cancer‐specific survival in patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy , 2013, International journal of urology : official journal of the Japanese Urological Association.

[15]  N. Nonomura,et al.  Impact of hyponatremia on survival of patients with metastatic renal cell carcinoma treated with molecular targeted therapy , 2012, International journal of urology : official journal of the Japanese Urological Association.

[16]  S. Shariat,et al.  Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study , 2012, BJU international.

[17]  X. Lei,et al.  Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  J. Coleman,et al.  Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle‐invasive and non‐organ confined disease in patients with upper tract urothelial carcinoma , 2012, BJU international.

[19]  O. Hansen,et al.  The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period. , 2010, Lung cancer.

[20]  N. Marcussen,et al.  Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma , 2010, British Journal of Cancer.

[21]  L. Price,et al.  Impact of hospital-associated hyponatremia on selected outcomes. , 2010, Archives of internal medicine.

[22]  S. Waikar,et al.  Mortality after hospitalization with mild, moderate, and severe hyponatremia. , 2009, The American journal of medicine.

[23]  K. Bensalah,et al.  Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi‐institutional analysis of 1363 patients , 2009, BJU international.

[24]  W. Lui,et al.  The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[25]  A. Shorr,et al.  Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients* , 2008, Current medical research and opinion.

[26]  N. Vasudev,et al.  Prognostic Factors in Renal Cell Carcinoma: Association of Preoperative Sodium Concentration with Survival , 2008, Clinical Cancer Research.

[27]  Joon-Oh Park,et al.  Clinical Outcome of Gastric Cancer Patients with Bone Marrow Metastases , 2008, Oncology.

[28]  L. Gandhi,et al.  Paraneoplastic syndromes associated with small cell lung cancer. , 2006, Journal of the National Comprehensive Cancer Network : JNCCN.

[29]  M. Paesmans,et al.  A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis , 2000, Supportive Care in Cancer.

[30]  W. Gregory,et al.  Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma. , 1993, British Journal of Cancer.